Two New Glucosides from Radix Polygoni multiflori Preparata

2,3,5,4'-tetrahydroxystilbene-2-O-(2'-O-feruloyl)-beta -D-glucopyranoside, 2,3,5,4'-tetra hydroxystilbene-2-O-(2'-O-p-coumaroyl)-beta -D-glucopyranoside were isolated from Radix Polygoni multiflori Preparata. Structures were elucidated by chemical and spectral evidences.

Radix Polygoni Multiflori Praeparata and Dioscorea Bulbifera Rhizome Decoctions Display Combined Effects Detected by a Three-Probe Drug Cocktail with Substrates of Rat Hepatic Cytochrome P450 Enzymes

Objectives: Radix Polygoni Multiflori Praeparata (RPMP) and Dioscorea Bulbifera Rhizomes (DBR) are used in Chinese herbal medicine and have been frequently reported for adverse reactions on liver. In this research, we aimed to evaluate in vivo effects of RPMP and DBR on rat cytochrome P450 enzymes (CYP1A2, CYP2E1 and CYP3A2) with their respective substrates as probes. Methods: Rats were orally administered RPMP, DBR and RPMP/DBR combination at 12, 10 and (12 + 10) g/kg, respectively, or saline as a control, once daily for 7 days. Thereafter, a cocktail containing 10 mg/kg caffeine, 20 mg/kg chlorzoxazone and 10 mg/kg dapsone was tail vein injected to rats. At defined time points, plasma drug concentrations were simultaneously evaluated by HPLC. Pharmacokinetic parameters simulated by DAS software were used to assess RPMP and/or DBR effects on cytochrome P450 enzymes activity. ANOVA and Dunnett’s test were used for data analysis. Results: Caffeine metabolism was enhanced in RPMP animals and reduced after pretreatment with DBR, but no effect was observed in RPMP/DBR combination group. Chlorzoxazone and dapsone metabolism was enhanced in both RPMP and DBR groups and consequently in combination group. The data suggested that RPMP independently induces rat CYP1A2, CYP2E1 and CYP3A2 activity, while DBR independently inhibits activity of rat CYP1A2 and induces that of CYP2E1 and CYP3A2. RPMP/DBR combination showed no significant benefit compared with the two drugs alone and even showed a neutralized effect in CYP1A2 activity. Conclusions: Caution is needed when RPMP and/or DBR are co-administered with drugs metabolized by human CYP1A2, CYP2E1 and CYP3A4.

Efficacy of Heshouwu(Radix Polygoni Multiflori)on gut mircobiota in mice with autoimmune encephalomyelitis

OBJECTIVE:To learn the mechanisms between gut microbiome and the autoimmunity benefits on Traditional Chinese Medicine(TCM)in central nervous system(CNS),we investigated the neuro-protection effects and gut mircobiota changes of Heshouwu(Radix Polygoni Multiflori)on experimental autoimmune encephalomyelitis(EAE),an animal model of multiple sclerosis(MS).METHODS:Mice were randomly divided into four groups:EAE mice(control phosphate-buffered saline group),50 mg·kg^(-1)·d^(-1)Heshouwu(Radix Polygoni Multiflori)-treated EAE mice,100 mg·kg^(-1)·d^(-1)Heshouwu(Radix Polygoni Multiflori)-treated EAE mice,and 200 mg·kg^(-1)·d^(-1)Heshouwu(Radix Polygoni Multiflori)-treated EAE mice.The spinal cords were stained with hematoxylin and eosin(HE)and luxol fast blue for evaluating inflammatory infiltration and demyelination.The percentages of granulocyte macrophage-colony stimulating factor(GM-CSF)+CD4+,interleukin 17(IL-17)+CD4+,Foxp3 CD4+,and interferon-γ(IFN-γ)+CD4+T cells in the inguinal lymph nodes(LNs)and brain were determined by flow cytometry analysis.16S rRNA gene sequencing was employed to analyze the changes in gut microbiota.RESULTS:We found that Heshouwu(Radix Polygoni Multiflori)alleviated the disease severity and neuropathology of EAE as evaluated by clinical and histopathologyical scores.Heshouwu(Radix Polygoni Multiflori)increased the diversity and abundance of the gut microbiota,and decreased Firmicutes/Bacteroidetes ratio(F/B ratio).Heshouwu(Radix Polygoni Multiflori)also decreased the concentrations of IL-10,and IL-21 and increase the levels of GM-CSF,IL-17A,IL-17F and IL-22 in serum of EAE mice.Moreover,Heshouwu(Radix Polygoni Multiflori)modulated the T cell responses by inhibiting Th17 cells and restoring Treg cells in the small intestine lymphoid tissues and inguinal lymph nodes.Microbiota-depleted mice receiving Heshouwu(Radix Polygoni Multiflori)-treated fecal microbiota transplantation had lower disease severity,neuropathology scores and alleviation of Th17/Treg imbalance compared to ad libitum group.CONCLUSIONS:Our findings suggested that the vital neuro-protection role of Heshouwu(Radix Polygoni Multiflori)(TCM)in immunomodulation effects partly by regulations of gut microbiome.

Chronic toxicity of both raw and processed Polygoni Multiflori Radix on rats

Recently, adverse effects of Polygoni Multiflori Radix（PMR） and Polygoni Multiflori Radix Praeparata（PMRP） have attracted intensive attention worldwide. These adverse effects most occurred in cases with high dose of prolonged medication course. Liver is usually the target organ of these adverse effects. In the present research, we performed in vivo chronic toxicity study and aimed to evaluate relationships between major constituents of water extractions and total anthraquinone of PMR and PMRP and chronic toxicity. SD rats of both sexes were given water extractions as well as total anthraquinone of PMR and PMRP for 12 weeks. We evaluated basic biochemical indexes, conducted microscopic observations of main organs and assessed early indicators of liver and renal fibrosis. Simvastatin, with hypertriglyceridemia and hypercholesterolemia as its main therapeutic areas, was investigated in our study. Component-toxicity relationships were also discussed. Five male rats died in our study, while all female rats survived, suggesting that some gender differences might be involved. Body weight was significantly changed, and basic biochemical indexes were sporadically occurred during the research. Pathological examinations on liver and kidney showed slight alternations after 12 weeks without dose-dependent relationship. Increase in serum laminin（LN） was observed in almost all male rats, indicating that the risks of liver or kidney fibrosis still existed, especially for males, although no fibrosis was found in the pathological examination of liver and kidney. No major and severe adverse effects were observed after 12 weeks of administration of PMR and PMRP. Regular safety monitoring is still necessary during medication in order to prevent possible risks.

天麻首乌片致严重肝损伤1例分析

目的 探讨严重肝损伤与天麻首乌片的相关性。方法 通过1例服用天麻首乌片导致严重肝损伤的不良反应,梳理其组方中药肝毒性的文献研究结果,采用《中国药物性肝损伤诊治指南(2023年版)》相关标准及更新后的RUCAM量表对肝损伤分型及与天麻首乌片的因果关系进行评估,探讨治疗策略的合理性。结果 天麻首乌片中制何首乌和炒蒺藜可能造成肝损伤,本例患者肝损伤为肝细胞损伤型,RUCAM评分7分(很可能),治疗策略通常包括保肝、利胆、抗炎等。文献分析发现,人类白细胞抗原(HLA)-B*35:01等位基因是何首乌肝损伤的风险因素,可作为预测何首乌所致肝损伤的潜在生物标志物。结论 本例患者严重肝损伤与天麻首乌片存在相关性;药品上市许可持有人应主动监测相关品种的不良反应,并及时更新说明书,减少患者用药风险。

何首乌化学成分、药理作用及肝毒性的研究进展

从化学成分、药理作用及肝毒性3个方面综述何首乌的研究进展。何首乌含有二苯乙烯苷类、蒽醌类、磷脂类、黄酮类等多种化学成分,具有延缓衰老、抗癌、抗疲劳、抗炎镇痛、保护心血管等药理作用。目前,何首乌引起肝毒性的化学成分探讨主要集中于3类,即蒽醌类、二苯乙烯苷类及鞣质类。加大何首乌肝毒性成分、肝毒性机制研究的力度,加强中药安全用药知识宣教,规范其炮制及使用,可以在一定程度上降低何首乌肝毒性。

近红外光谱法快速检测何首乌炮制过程中多糖含量的研究

该研究基于近红外光谱技术建立了何首乌在蒸制过程中多糖含量变化的快速定量模型。采用蒽酮浓硫酸法测定了不同蒸制时间何首乌的多糖含量并结合采集的近红外光谱数据建立模型,以校正集相关系数(R^(2)_(c))、预测集相关系数(R^(2)_(p))、交叉验证集均方根误差(RMSECV)和预测集均方根误差(RMSEP)作为评价指标,考察了不同预处理方法和变量筛选方法的效果。结果显示,随着蒸制时间的延长,何首乌多糖含量先上升后下降并趋于平稳,采用平滑+变量标准化+随机蛙跳变量筛选建立的偏最小二乘法回归模型的R^(2)_(c)=0.96,RMSECV=0.74,R^(2)_(p)=0.96,RMSEP=0.28;外部预测相对偏差小于3.0%。所建立的多糖含量定量模型质量较高,预测能力较强,可为探索何首乌炮制工艺标准化及质量评价提供参考。

5-HMF高效液相色谱检测方法的建立及功能糖与不同产地党参、何首乌和熟地中5-HMF含量分析

本试验旨在建立5-羟甲基糠醛(5-hydroxymethylfurfural,5-HMF)的高效液相色谱检测方法,检测不同产地党参、制首乌、熟地黄以及5个不同批次功能糖中5-HMF含量。采用C_(18)(4.6 mm×250.0 mm,5μm)色谱柱分离,流动相为甲醇-水(8∶92),流速为1.0 mL/min,柱温为30℃,进样量为10μL,紫外检测器,检测波长为280 nm。经方法学考察,显示该方法线性关系良好;精密度试验测定峰面积RSD平均值为1.438%;重复性试验显示HPLC重复性良好;稳定性试验峰面积RSD范围为1.338%~7.307%;加标回收率显示良好。中药及功能糖5-HMF含量检测结果显示,党参、制首乌和熟地黄相比,熟地黄中5-HMF含量较高,党参中5-HMF含量较低,其中又以河北产熟地黄中5-HMF含量最高。不同批次功能糖中5-HMF含量无显著性差异,但其含量是河北产熟地黄的90~100倍。通过现代化技术,用功能糖成功复制了中药中的活性成分5-HMF,降低了其生产成本,具有良好的发展前景。

何首乌-牛膝药对抗维甲酸诱导骨质疏松作用及活性成分筛选研究

目的研究何首乌-牛膝药对的抗骨质疏松作用及筛选活性成分。方法采取液相色谱-质谱(HPLC-MS)联用法分析何首乌-牛膝药对指纹共有峰并进行成分确认;采用维甲酸复制大鼠骨质疏松模型及酶联免疫吸附(ELISA)方法,探讨何首乌-牛膝药对的抗骨质疏松作用;应用SPSS分析色谱结果与肝、肾湿重、骨干湿比数据和ELISA测定结果的相关性筛选何首乌-牛膝药对抗骨质疏松活性成分。结果HPLC-MS联用法分析结果共确定10个共有指纹峰成分,分别为:没食子酸、杯苋甾酮、β-蜕皮甾酮、25-R-牛膝甾酮、二苯乙烯苷、25-S-牛膝甾酮、大黄素、大黄素甲醚、齐墩果酸-3-O-β-D-葡萄糖醛酸苷、牛膝皂苷D。生物学指标测定结果表明何首乌-牛膝药对能使维甲酸所致骨质疏松大鼠血清骨碱性磷酸酶(BALP)和骨钙素(BGP-OCN)指标升高,抗酒石酸酸性磷酸酶5b(TRACP-5b)和血清I型胶原C端肽(CTX-1)降低;何首乌-牛膝药对组肝、肾指数明显下降,骨干湿比上升,体质量变化明显。结论何首乌-牛膝药对具有抗骨质疏松作用,筛选出作用最显著活性成分为没食子酸、β-蜕皮甾酮、大黄素和齐墩果酸-3-O-β-D-葡萄糖醛酸苷。

何首乌延缓衰老机制探析

何首乌始载于宋代《开宝本草》,是临床常用的大宗药材之一。何首乌素有延缓衰老之灵药的美称,具有补肝肾、益精血、补虚损、黑须发等功效,被广泛用于预防和治疗衰老等相关疾病。何首乌的主要活性成分是二苯乙烯苷、多糖、蒽醌类等,具有增强免疫、抗氧化、延缓衰老、抗炎、降血脂及神经保护等药理作用。该文综述了何首乌对皮肤系统、阿尔茨海默病、动脉粥样硬化及帕金森病等衰老相关疾病的影响以及延缓衰老的作用机制,以期为何首乌在延缓老化方向的应用奠定理论基础。

制何首乌对脑卒中后抑郁大鼠神经功能的改善作用

目的探讨制何首乌对脑卒中后抑郁(PSD)大鼠的作用及其机制。方法采用线栓法建立脑中动脉阻塞模型(MCAO),将大鼠随机分为模型组、氟西汀组和制何首乌低、高剂量组,每组10只,另设假手术组。于MCAO造模7d后对除假手术组外的其他大鼠进行持续21d的PSD造模,于第1、7、14、21天进行神经功能及行为学评分,第21天,检测脑梗死面积、脑含水量,采用HE染色、尼氏染色及免疫组化染色观察脑缺血半暗带区病理学形态,ELISA及Westernblot法检测脑组织水通道蛋白(AQP3、AQP4、AQP5)及脑源性神经营养因子(BDNF)蛋白表达。结果与模型组比较,制何首乌高剂量组可改善神经功能及行为学评分(P<0.05,P<0.01),降低脑梗死面积和脑含水量(P<0.05)。与模型组比较,各给药组缺血半暗带区脑部结构清晰,细胞间隙变小,神经元数量增多,脑组织AQP3、AQP4、AQP5蛋白表达降低(P<0.05,P<0.01),而BDNF蛋白表达升高(P<0.05)。结论制何首乌可通过降低AQP3、AQP4、AQP5蛋白表达,消除脑水肿,提高BDNF蛋白表达,改善神经元微环境,促进神经元的生长存活,增强神经功能,从而减弱PSD大鼠的抑郁程度。

制何首乌的炮制工艺、化学成分和药理活性研究进展

制何首乌是何首乌Polygonum multiforum Thunb.的炮制加工品,主要成分包括二苯乙烯苷类、蒽醌类、黄酮类、生物碱类、酚酸类等,具有抗氧化、补血、抗肿瘤、降血糖、抗炎等药理作用,临床上使用广泛。炮制工艺主要为黑豆汁炖制、蒸制、九蒸九制和炆制,炮制后颜色加深,成分含量也会发生变化。通过查阅国内外文献,发现对制何首乌的研究相较于何首乌而言不够全面,因此对近20年来报道的制何首乌炮制工艺、化学成分、药理活性的研究进行系统综述,为进一步开发制何首乌提供参考。

炆何首乌乌发的药效评价及其网络药理学机制研究

目的:对炆何首乌乌发的药效进行评价,并对其作用机制进行研究。方法:构建小鼠白发模型,通过白发面积在新生毛发区域占比、苏木精-伊红(HE)染色及血浆中酪氨酸酶(TYR)的含量来评价炆何首乌的乌发作用;并利用网络药理学及免疫荧光探讨其作用机制。结果:与假手术组比较,模型组小鼠背部白发面积明显升高,皮肤组织中含黑色素的毛囊数量明显降低,血浆中TYR含量明显降低。与模型组比较,阳性药、制何首乌(中剂量、高剂量)及炆何首乌(低剂量、中剂量、高剂量)均能明显降低小鼠白发面积;制/炆何首乌低剂量、中剂量、高剂量能够明显增加小鼠皮肤组织中黑色素毛囊数量;制/炆何首乌高剂量可以明显提高小鼠血浆中TYR含量。在生药量相同的条件下,与制何首乌比较,炆何首乌中剂量能明显增加黑色素毛囊数量;炆何首乌低剂量、高剂量能明显增加小鼠血浆中TYR含量。网络药理学分析发现,炆何首乌的乌发作用涉及黑色素生成和Wnt信号通路等。免疫荧光结果表明,与假手术组比较,模型组小鼠皮肤组织中淋巴增强结合因子1(LEF1)及TYR表达水平明显降低;炆何首乌组小鼠皮肤组织中LEF1及TYR表达水平均明显增高。结论:炆何首乌对小鼠白发模型具有一定的改善作用,其作用机制可能与上调LEF1及TYR的表达水平有关。

Enhanced absorption and inhibited metabolism of emodin by 2,3,5,4＇-tetrahydroxystilbene-2-O-β-D-glucopyranoside： Possible mechanisms for Polygoni Multiflori Radix-induced liver injury

Polygoni Multiflori Radix(PMR) has been commonly used as a tonic in China for centuries. However, PMR-associated hepatotoxicity is becoming a safety issue. In our previous in vivo study, an interaction between stilbenes and anthraquinones has been discovered and a hypothesis is proposed that the interaction between stilbene glucoside-enriching fraction and emodin may contribute to the side effects of PMR. To further support our previous in vivo results in rats, the present in vitro study was designed to evaluate the effects of 2, 3, 5, 4'-tetrahydroxystilbene-2-O-β-D-glucopyranoside(TSG) on the cellular absorption and human liver microsome metabolism of emodin. The obtained results indicated that the absorption of emodin in Caco-2 cells was enhanced and the metabolism of emodin in human liver microsomes was inhibited after TSG treatment. The effects of the transport inhibitors on the cellular emodin accumulation were also examined. Western blot assay suggested that the depressed metabolism of emodin could be attributed to the down-regulation of UDP-glucuronosyltransferases(UGTs) 1A8, 1A10, and 2B7. These findings definitively demonstrated the existence of interaction between TSG and emodin, which provide a basis for a better understanding of the underlying mechanism for PMR-induced liver injury.

何首乌及其中成药制剂导致的中草药相关肝损伤的回顾性研究

目的:观察何首乌、润燥止痒胶囊和百乐眠胶囊引起的中草药相关肝损伤(HILI)在接受中医药治疗人群中的可能发生率,探索其危险因素。方法:以2020年1月至2022年6月在上海中医药大学附属曙光医院门诊接受中医药治疗时曾运用何首乌、润燥止痒胶囊、百乐眠胶囊的患者为研究对象,分析HILI发生的可能性。结果:运用何首乌导致HILI的可能发生率为2.64‰,运用润燥止痒胶囊导致HILI的可能发生率为2.40‰,运用百乐眠胶囊导致HILI的可能发生率为2.06‰。甲状腺疾病是影响服用百乐眠胶囊患者HILI发生的危险因素(P<0.001)。结论:何首乌及其中成药制剂导致的中草药相关肝损伤发生率较低,应当正确评价中草药相关肝损伤,安全合理应用中药。

康寿丸质量标准提升研究

目的提升康寿丸的质量标准。方法采用薄层色谱(TLC)法对康寿丸中的人参、地骨皮、何首乌进行定性鉴别;采用高效液相色谱法测定制剂中2,3,5,4'-四羟基二苯乙烯-2-O-β-D-葡萄糖苷(简称二苯乙烯苷)的含量,色谱柱为Phenomenex C18柱(250 mm×4.6 mm,4µm),流动相为乙腈-水(19∶81,V/V),流速为1.0 mL/min,检测波长为320 nm,柱温为25℃,进样量为10µL。测定2家生产厂家各10批样品中二苯乙烯苷的含量,并制订其含量限度。结果人参、地骨皮和何首乌的薄层色谱图主斑点清晰,分离度良好,且阴性对照无干扰。二苯乙烯苷的进样量在30.094~3761.7 ng范围内与峰面积积分值线性关系良好(r=1.000,n=11);精密度、稳定性、重复性试验结果的RSD均小于2.0%;平均加样回收率为102.88%,RSD为0.59%(n=8)。10批样品中二苯乙烯苷含量介于1.14~3.32 mg/g。结论所建立的方法专属性强、重复性好、准确度高,可用于康寿丸的质量控制。暂订每1 g寿康丸含何首乌以二苯乙烯苷计不得少于0.90 mg。

Chemical profiles and metabolite study of raw and processed Polygoni Multiflori Radix in rats by UPLC-LTQ-Orbitrap MS^n spectrometry

The raw and processed roots of Plygonum multiflorum Thunb(PM) are used to treat different diseases in clinical practice. In order to clarify the influence of processing, a comparative study of chemical substance analysis was carried out. As the xenobiotics with a high enough exposure in target organs being considered as the potential effective or toxicity components, an in vivo study was also implemented to characterize the constitutes and metabolites, and meanwhile, the factor of compatibility with black bean were also considered. As a result, a total of 148 compounds were detected in PM extracts and more than 40 compounds were only detected in the processed products, which were probably new components produced during the steaming process. In in vivo study, 7 prototype components and 66 metabolites were detected or tentatively identified, 24 of which were reported for the first time. Our results indicated that processing greatly changed the chemical composition of PM and influenced the disposition of the compounds in vivo. To the best of our knowledge, this was the first global comparative study of raw and processed PM. These results expanded our knowledge about the influence of processing of PM and provided the essential data for further efficacy or toxicity studies.

基于特征图谱及多成分定量的首乌藤饮片与标准汤剂量值传递规律研究

本文建立首乌藤的含量测定方法和指纹图谱评价方法,研究首乌藤饮片到标准汤剂的量值传递规律。收集全国主产地和道地产地具有代表性的20批首乌藤药材,按《中国药典》2020年版规定制备成首乌藤饮片,并按《中药配方颗粒质量控制与标准制定技术要求》制备成首乌藤标准汤剂;采用HPLC建立适用测定含量及指纹图谱方法,以转移率、出膏率及指纹图谱相似度为指标,分析首乌藤饮片到标准汤剂的量值传递规律。结果显示,20批首乌藤标准汤剂出膏率为10.4%~16.1%,均值为12.9%,均位于均值的±30%范围内。除了四川产地的样品外,其余产地首乌藤饮片及其标准汤剂HPLC对照指纹图谱相似度均良好(>0.9),且二者具6个共有峰,并通过对照品指认其中的4个峰分别2,3,5,4-四羟基二苯乙烯-2-O-β-D-葡萄糖苷、大黄素-8-O-β-D-葡萄糖苷、大黄素、大黄素甲醚。四个已知成分的转移率分别为26.58%~53.07%(2,3,5,4-四羟基二苯乙烯-2-O-β-D-葡萄糖苷)、12.37%~42.84%(大黄素-8-O-β-D-葡萄糖苷)、3.83%~18.71%(大黄素)、0.35%~4.13%(大黄素甲醚)。本文建立了首乌藤饮片及其标准汤剂含量测定方法和指纹图谱方法,阐明了二者之间的化学成分的量值传递规律,为首乌藤水提物及其配方颗粒质量控制提供参考。

指纹图谱技术结合化学计量学方法鉴别制首乌产地的研究

目的建立一种指纹图谱技术结合化学计量学方法的制首乌产地快速鉴别方法。方法建立33批不同产地制首乌的指纹图谱并对其进行相似度评价,对色谱峰信息进行偏最小二乘判别法分析(PLS-DA)和线性判别分析。结果以对照指纹图谱为参照,不同批次药材间化学成分及含量差异较小,采用指纹图谱结合相似度的评价方法无法对其产地进行区分;选取PLS-DA分析法,基于变量权重重要性排序(VIP)值确定其中的差异标志物,由此建立不同产地制首乌的线性判别函数模型并对不同产地制首乌进行预测,模型对测试集的验证结果良好。结论指纹图谱技术结合化学计量学方法可作为一种有效鉴别不同产地制首乌的方法。

何首乌肝损伤风险的发现、评价与防控策略研究

近年来,中草药相关的不良反应/事件频繁被报道,尤其针对新发现“有毒”中药的安全性问题,往往难以做出科学的回答并制定有效解决方案。中药由于自身的复杂性及缺乏系统性研究,使得我们对中草药相关肝损伤的成因机制了解有限。因此,破解中草药安全性难题亟需在中药毒性认知及安全风险防控方面实现突破。笔者团队以何首乌肝损伤作为典型范例,基于首创中药药源性肝损伤因果关系评价“整合证据链法”,证实了何首乌致肝损伤的客观真实性。进一步基于团队创新性建立的病证毒理学方法,科学揭示了何首乌肝损伤的物质基础及成因机制,也提出并证实了中药免疫特异质肝损伤“三因致毒”机制假说。在此基础上,阐明了何首乌特异质肝损伤易感人群的病证特征,并筛选发现了多种生物标志物,包括基因标志物HLA-B*35:01、免疫学及代谢组标志物。最后,探索创建了基于易感人群识别、易感物质控制以及个性化用药的“人-药-用”三维风险防控的安全用药策略和方法,为全面揭示“有毒”中药毒副反应科学内涵并建立科学有效的风险防控对策提供了基础。